• Thallium/Creatinine Ratio, Random, Urine
  • Estradiol, Serum
  • HLA Class I and II typing, Antigen or Genotyping
  • Phenosense Combination HIV Drug Resistance Assay
  • Toxoplasma gondii Antibody, IgM
  • Islet Cell (IA-2) Autoantibodies
  • Peutz-Jeghers Syndrome (STK11) Gene Mutation Analysis
  • MYC (8q24) Gene Rearrangement by FISH
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /BCR-ABL Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

BCR-ABL Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test

CPT
Access to BCR-ABL Mutation Analysis for Tyrosine Kinase Inhibitor Resistance is restricted.